[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP3344244A1 - Verwendung von indolverbindungen zur stimulierung des immunsystems - Google Patents

Verwendung von indolverbindungen zur stimulierung des immunsystems

Info

Publication number
EP3344244A1
EP3344244A1 EP16757898.8A EP16757898A EP3344244A1 EP 3344244 A1 EP3344244 A1 EP 3344244A1 EP 16757898 A EP16757898 A EP 16757898A EP 3344244 A1 EP3344244 A1 EP 3344244A1
Authority
EP
European Patent Office
Prior art keywords
compound
subject
anyone
hiv
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP16757898.8A
Other languages
English (en)
French (fr)
Inventor
Jacques Theze
Blanche TAMARIT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diaccurate SA
Original Assignee
Diaccurate SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diaccurate SA filed Critical Diaccurate SA
Priority claimed from PCT/EP2016/070367 external-priority patent/WO2017037041A1/en
Publication of EP3344244A1 publication Critical patent/EP3344244A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Definitions

  • R2 is a C1 -C3 alkyl, preferably ethyl ;

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP16757898.8A 2015-08-31 2016-08-30 Verwendung von indolverbindungen zur stimulierung des immunsystems Withdrawn EP3344244A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2015306333 2015-08-31
PCT/EP2016/070367 WO2017037041A1 (en) 2015-08-31 2016-08-30 Use of indole compounds to stimulate the immune system

Publications (1)

Publication Number Publication Date
EP3344244A1 true EP3344244A1 (de) 2018-07-11

Family

ID=62292361

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16757898.8A Withdrawn EP3344244A1 (de) 2015-08-31 2016-08-30 Verwendung von indolverbindungen zur stimulierung des immunsystems

Country Status (1)

Country Link
EP (1) EP3344244A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018221654A1 (de) 2018-12-13 2020-06-18 Eberspächer Catem Gmbh & Co. Kg PTC-Heizelement und Verfahren zu dessen Herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018221654A1 (de) 2018-12-13 2020-06-18 Eberspächer Catem Gmbh & Co. Kg PTC-Heizelement und Verfahren zu dessen Herstellung

Similar Documents

Publication Publication Date Title
US10894035B2 (en) Use of indole compounds to stimulate the immune system
CN114191552B (zh) 抗新型冠状病毒SARS-CoV-2的药物及其应用
JP5363152B2 (ja) グリシン捕捉性アンタゴニストを用いる拒絶性および認知性精神分裂病症候群の処置
BR112019016316A2 (pt) Métodos para o tratamento da influenza
US10004744B2 (en) Therapeutic approaches for treating Parkinson's disease
US11154587B2 (en) Use of peptides to stimulate the immune system
US20220193053A1 (en) Cystic fibrosis transmembrane conductance regulator modulators for treating autosomal dominant polycystic kidney disease
Hashimoto et al. A CD4 mimic as an HIV entry inhibitor: Pharmacokinetics
Wang et al. Inhibition of acetaminophen-induced hepatotoxicity in mice by exogenous thymosinβ4 treatment
CN110177463B (zh) 2-羟基苄胺在治疗和预防肺动脉高压中的应用
US11517581B2 (en) Zika virus protease inhibitors and methods of use thereof
EP3344244A1 (de) Verwendung von indolverbindungen zur stimulierung des immunsystems
US20240115588A1 (en) Use of proteasome inhibitors in the treatment of coronavirus infections
CA2638448A1 (en) Methods for preventing and treating tissue injury and sepsis associated with yersinia pestis infection
WO2022113008A1 (en) Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder
WO2021151964A1 (en) Use of azole compounds to stimulate the immune system and as inhibitors for s-pla2gib
Zhang Development of cyclophilin inhibitors for the treatment of pancreatitis
CN114555089A (zh) 用于乙型肝炎治疗的化合物
US20170049727A1 (en) Use of N-Acetylcysteine Amide in the Treatment of Acquired Immune Deficiency Syndrome and HIV Infection

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20180314

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190404

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20230301